The Randox Clinical Laboratories Services (RCLS) team strives to meet the time sensitive, custom-made requirements of research and clinical projects. Accordingly, RCLS is also able to provide support and guidance. They specialise in biomarker and multiplex testing which provide full laboratory services to aid project aims and timelines whilst saving time and money. Currently, there are four laboratories across the UK located in Liverpool, London, Holywood and the Randox Science Park in Antrim.

In 2017 approximately 422,000 diagnoses of STIs were made in England¹ and over one million STIs are acquired every day ².

Sexually transmitted infections (STIs) are a viral or bacterial infection passed from one person to another through unprotected sexual contact.³ Most STIs are curable however, it takes time for the symptoms to appear or show up in tests. Others have no cure, such as HIV, but can be treated to prevent the disease getting worse. Common symptoms of STIs include vaginal discharge, urethral discharge or burning in men, genital ulcers, and abdominal pain ² although, a person can have an STI without having obvious symptoms of disease.

Randox Clinical Laboratory Services offers a multiplex sexually transmitted infection array allowing you to outsource sample STI testing. It includes common STIs such as Chlamydia, Gonorrhoea, Syphilis, Herpes Simplex I, Herpes Simplex II. The full Multiplex Array can be seen below.

The simultaneous detection is made possible by our award-winning and innovative Biochip Array Technology which utilises multiplex testing methodology in a rapid and accurate format. The type of sample which is sent to our RCLS lab is determined by the visibility of the symptoms. Non-visible symptoms will require a urine sample whereas visible symptoms will require a swab sample.

There are many benefits to outsourcing your STI samples with RCLS, which include the following:

• CE-marked
• ISO17025 Accredited Laboratories
• Excellent precision, specificity, sensitivity and accuracy for diagnosis
• Reduced risk of false reporting and a reduced number of unnecessary tests
• Smaller sample volumes are required therefore enabling faster throughput and rapid patient diagnosis

STI Multiplex Array:

• Chlamydia trachomatis
• Neisseria gonorrhoea
• Herpes simplex 1
• Herpes simplex 2
• Treponema pallidum
• Mycoplasma hominis
• Ureaplasma urealticum
• Mycoplasma genitalium
• Haemophilius ducreyi
• Trichomonas vaginalis

If you would like more information on RCLS or our STI testing please contact info@rcls.com

1. https://www.gov.uk/government/news/new-data-reveals-420000-cases-of-stis-diagnosed-in-2017
2. http://www.who.int/en/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis)
3. https://sexualhealthdorset.org/sexually-transmitted-infections-stis

To find out more about our Biochip Array Technology and our Evidence Series analysers, visit www.randoxtoxicology.com, or email us at info@randoxtoxicology.com